All In Biotech

Free tool

FAERS Monitor: Inrebic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212327 or its brand name (Inrebic, Fedratinib Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

1,349

Serious

687

51% of reports

Hospitalization

266

Death reported

191

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea146
  • death141
  • nausea122
  • fatigue115
  • vomiting73
  • constipation59
  • off label use58
  • haemoglobin decreased54
  • asthenia52
  • platelet count decreased50
  • full blood count decreased45
  • pruritus42
  • anaemia41
  • dizziness40
  • drug ineffective40

Reports by year received

View as table
YearReports
20161
20171
20182
201946
2020273
2021282
2022246
2023184
2024145
2025106
202663

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,810 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (500). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
full blood count decreasedSignal4534.926.21,446
haemoglobin decreasedSignal548.26.3336
diarrhoeaSignal1463.53.0270
anaemiaSignal413.42.566
deathSignal1412.62.2137
vomitingSignal732.41.961
nauseaSignal1222.42.0102
fatigueSignal1152.31.987
astheniaSignal522.21.732
pruritus421.71.312
dizziness401.30.92
off label use581.00.80
drug ineffective400.50.324
constipation590.00.0905,229
platelet count decreased500.00.0764,784

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.